Fig. 7

TME and sensitivity to immune checkpoint inhibitors analysis of high- and low-risk groups. A Association of high- and low-risk groups with stromal, immune, and ESTIMATE algorithm scores (***p < 0.001). B Immune cell infiltration landscape. C Differences in immune cell infiltration between high- and low-risk groups. D Differences in immune function scores between high- and low-risk groups. Boxplot of PD1 (E), PD-L1 (F), CTLA-4 (G), IL-6 (H), and LAGE (I) expression in different risk groups. Four types of IPS classification based on risk score grouping [CTLA4-neg-PD1-neg (J), CTLA4-neg-PD1-pos (K), CTLA4-pos-PD1-neg (L), and CTLA4-pos-PD1-pos (M)]